Scinovex
article Open AccessTop 1% cited

The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level

Oncogene · 2008 · Vol. 27(25) · pp. 3576–3586
Issam Ben SahraKathiane LaurentAgnès LoubatSophie Giorgetti‐PeraldiPascal ColosettiPatrick AubergerJean‐François TantiY. Le Marchand‐BrustelFrédéric Bost
Metabolism, Diabetes, and CancerCancer-related Molecular PathwaysCancer, Hypoxia, and MetabolismMetforminDU145LNCaPAMPKBiologyCyclin D1Cell growthCancer researchPharmacologyEndocrinology

MeSH terms

Antineoplastic AgentsCell SurvivalHumansHypoglycemic AgentsMaleMetforminMultienzyme ComplexesProstateProstatic NeoplasmsGene Expression Regulation, NeoplasticApoptosisProtein Serine-Threonine KinasesCyclin D1Cell Line, TumorCell Proliferation
Citations
849
FWCI
18.21
field-weighted impact
References
42
Percentile
100%
vs. same field & year
Citations per year
Cited by
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.